Journal article
Clinical Impact of Residual Extraretroperitoneal Masses in Patients With Advanced Nonseminomatous Germ Cell Testicular Cancer
Abstract
OBJECTIVE: Integration of platinum-based chemotherapy and surgical resection of residual masses is essential in the management of advanced nonseminomatous germ cell tumors (NSGCT). We reviewed our institutional experience in patients undergoing resection of extraretroperitoneal (ERP) residual masses after chemotherapy to assess its impact on cancer progression and survival.
METHODS: Between 1989 and 2003, 532 patients with advanced NSGCT …
Authors
Masterson TA; Shayegan B; Carver BS; Bajorin DF; Feldman DR; Motzer RJ; Bosl GJ; Sheinfeld J
Journal
Urology, Vol. 79, No. 1, pp. 156–159
Publisher
Elsevier
Publication Date
January 2012
DOI
10.1016/j.urology.2011.09.038
ISSN
0090-4295
Fields of Research (FoR)
Medical Subject Headings (MeSH)
Chemotherapy, AdjuvantCohort StudiesDisease ProgressionDisease-Free SurvivalHumansKaplan-Meier EstimateLymph Node ExcisionLymph NodesMaleMultivariate AnalysisNeoplasm InvasivenessNeoplasm StagingNeoplasm, ResidualNeoplasms, Germ Cell and EmbryonalOrchiectomyPrognosisProportional Hazards ModelsRetroperitoneal SpaceRetrospective StudiesRisk AssessmentSurvival AnalysisTeratomaTesticular NeoplasmsTreatment Outcome